Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

Drug Toxicity: Risk factors

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

Drug Toxicity: Dose-Dependent Reactions

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Validation of the Standardized Outcomes in Nephrology-Life Participation (SONG-LP) Instrument in People with CKD.

Kidney360·2026

Same author

Validation of the Standardized Outcomes in Nephrology - Life Participation (SONG-LP) Instrument in People Receiving Dialysis.

Kidney international reports·2026

Same author

Lipid-lowering for people with chronic kidney disease: a narrative review.

Drug and therapeutics bulletin·2026

Same author

Establishing a core outcome measure for cancer in trials in kidney transplantation: a standardized outcomes in nephrology-kidney transplantation consensus workshop report.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Same author

Australian adults' views on influenza vaccination: Implications for communication and service quality from a qualitative study.

Vaccine·2026

Same author

Graft survival and rejection with repeated human leukocyte antigen (HLA) mismatch in kidney transplantation: a retrospective multicentre cohort study protocol.

BMC nephrology·2026

Search research articles

Related Experiment Video

Updated: May 16, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Paracetamol in Pregnancy: Uncertain Evidence, Certain Consequences.

David J Tunnicliffe^1,2, Miranda Cumpston³, Debra Kennedy^4,5

¹School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.

The Medical Journal of Australia

|May 14, 2026

Summary

This summary is machine-generated.

A review falsely linked paracetamol use during pregnancy to autism. This analysis critiques the flawed review, highlighting how scientific uncertainty surrounding autism causes can be misused, causing public confusion about medication safety.

Keywords:

epidemiology guidelines as topic health communication pain pregnancy public health systematic review

Related Experiment Videos

Last Updated: May 16, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Area of Science:

Public Health
Epidemiology
Medical Ethics

Background:

Autism diagnoses have risen, sparking research into potential causes.
A recent systematic review, based on observational studies, suggested a link between paracetamol and autism.
This review has been cited publicly, causing concern regarding paracetamol safety during pregnancy.

Purpose of the Study:

To critically appraise a systematic review linking paracetamol to autism.
To examine the manipulation and amplification of scientific uncertainty in public health discussions.
To address public confusion regarding paracetamol use in pregnancy.

Main Methods:

Critical analysis of a systematic review's methodology and reporting.
Examination of the evidence base for observational studies in relation to causality.
Assessment of how scientific findings are presented and interpreted in the public domain.

Main Results:

The cited systematic review exhibited selective reporting and methodological flaws.
The review lacked sufficient causal evidence to support its conclusions.
The review's conclusions have contributed to public confusion and anxiety.

Conclusions:

The systematic review's conclusions regarding paracetamol and autism are not well-supported by the evidence presented.
Scientific uncertainty can be exploited to create misleading public health narratives.
Clearer communication and rigorous methodology are essential to prevent public confusion regarding medication safety in pregnancy.